Mark Aguillard
Corporate Officer/Principal bei DERMTECH, INC.
Vermögen: 52 650 $ am 30.04.2024
Aktive Positionen von Mark Aguillard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DERMTECH, INC. | Corporate Officer/Principal | 19.09.2023 | - |
Karriereverlauf von Mark Aguillard
Ehemalige bekannte Positionen von Mark Aguillard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.07.2021 | 01.09.2023 |
Ausbildung von Mark Aguillard
Texas Tech University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DERMTECH, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Mark Aguillard
- Erfahrung